<DOC>
	<DOCNO>NCT02186561</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness Pipeline™ device treatment unruptured , wide-neck intracranial aneurysm .</brief_summary>
	<brief_title>Prospective Study Embolization Intracranial Aneurysms With Pipeline™ Embolization Device</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Subject provide write informed consent use IRB/ECapproved consent form agree comply protocol requirement . Age 2280 year . Subject target intracranial aneurysm ( IA ) locate anterior posterior circulation . Subject target IA wide aneurysm neck . Subject receive intracranial implant ( e.g . coil ) area target IA within past 12 week . Major surgery last 30 day . History irreversible bleed disorder and/or subject present sign active bleeding . Any known contraindication treatment Pipeline™ device . Pregnant woman . Participating another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>intracranial aneurysm</keyword>
	<keyword>brain aneurysm</keyword>
</DOC>